Fatty Acid Synthesis
MCAT trap: Confuses the subcellular location of fatty acid synthesis with that of beta-oxidation. Fatty acid synthesis occurs in the cytosol, while beta-oxidation occurs in the mitochondrial matrix.
Fatty acid synthesis is the process by which cells build long-chain saturated fatty acids — primarily palmitate (16 carbons) — from acetyl-CoA units in the cytosol. The MCAT tests this in two main ways: direct recall of the machinery and contrast questions where you have to distinguish synthesis from beta-oxidation. The most persistent error: students learn beta-oxidation first and carry those details into synthesis incorrectly — defaulting to the mitochondrial matrix as the location and NADH as the reducing equivalent. Both are wrong for synthesis: it happens in the cytosol and uses NADPH, not NADH.
Passage-based questions often describe a metabolic state (fed, fasted, high insulin) and ask you to predict whether synthesis is active and which regulators are at play. The rate-limiting step is acetyl-CoA carboxylase (ACC), which makes malonyl-CoA and uses biotin as a cofactor — a detail the MCAT loves to probe.
The citrate shuttle is another gap that bites students. Acetyl-CoA is made in the mitochondrial matrix during pyruvate oxidation and fatty acid oxidation, but it cannot cross the inner mitochondrial membrane on its own. It exits as citrate, and ATP-citrate lyase in the cytosol regenerates acetyl-CoA from that citrate. If you see a question about where synthesis gets its substrate, the answer runs through citrate — not direct membrane crossing.
Common misconceptions
What the exam tests
- Know that fatty acid synthesis is cytosolic — acetyl-CoA cannot cross the inner mitochondrial membrane directly and must be exported as citrate via the citrate shuttle, then regenerated by ATP-citrate lyase in the cytosol.
- Identify acetyl-CoA carboxylase (ACC) as the rate-limiting enzyme; know it uses biotin as a cofactor, is activated allosterically by citrate, and is inhibited by palmitoyl-CoA and by PKA-mediated phosphorylation (triggered by glucagon or epinephrine).
- Know that NADPH — primarily sourced from the pentose phosphate pathway — is the reducing equivalent for fatty acid synthesis, and be able to explain why NADH is not used here.
- Contrast fatty acid synthesis with beta-oxidation across all key dimensions: location (cytosol vs. mitochondrial matrix), reducing equivalents (NADPH vs. FAD/NAD+), carrier (ACP vs. CoA), and building block (malonyl-CoA vs. acetyl-CoA cleavage).
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →